General Information of Drug (ID: DM1N8PZ)

Drug Name
rAAV1.tMCK.human-alpha-sarcoglycan Drug Info
Synonyms alpha-sarcoglycan adenoviral gene therapy
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM1N8PZ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Sarcoglycan alpha (SGCA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
SRP-9004 DMK095Z Limb girdle muscular dystrophy 8C70.4 Phase 1/2 [2]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sarcoglycan alpha (SGCA) TTS9Q5V SGCA_HUMAN Modulator [1]

References

1 Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
2 Clinical pipeline report, company report or official report of Sarepta Therapeutics.